MasterPharm Recalls Progesterone Capsules Due to Processing Control Deficiencies
MasterPharm LLC is recalling 600 capsules of Progesterone (Modified Release) 150 mg due to a lack of processing controls.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The source text explicitly identifies the recall as FDA Class II. According to the severity rubric, FDA Class II recalls are classified as Severe (Score 4), and the rule states that if the agency's classification is FDA Class I or II, the score must not be lower than 4.
Plain-English summary
MasterPharm LLC is recalling 600 capsules of Progesterone (Modified Release) 150 mg. The product is distributed nationwide in the U.S. The specific lot code is 02-05-2020:07@6, with a best-use date of 8/3/2020.
The recall was initiated because of a lack of processing controls, which means there is a lack of assurance that the product conforms to specifications. This is classified as an FDA Class II recall.
Consumers who have this product should stop using it and contact MasterPharm LLC at (866) 630-5600 for instructions on how to return or dispose of the medication.
The recalled product
- Product
- Progesterone (Modified Release) 150 mg Capsule, 90 capsules per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419, (866) 630-5600
- Manufacturer
- MasterPharm LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 600
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- 02-05-2020:07@6
- BUD 8/3/2020
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 26 recalled by MasterPharm LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 26 products in this recall →Related recalls
Same manufacturer · MasterPharm LLC
See all →- ModerateMasterPharm Recalls Tadalafil 12 mg Capsules Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Progesterone Troches Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Calcium Citrate Powder Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Formula 82M Due to Lack of Processing Controls
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Progesterone Troches Due to Lack of Processing Controls
FDA (Drugs) · 2020-08-05
Same hazard · processing defect
See all →- SevereWayne Farms Recalls Undercooked Ready-to-Eat Chicken Breast Products
USDA FSIS · 2023-12-07
- HighUndercooked Ready-to-Eat Stuffed Chicken Product Subject to Public Health Alert
USDA FSIS · 2023-02-03
- SevereWayne Farms Recalls Undercooked Ready-to-Eat Chicken Breast Fillets
USDA FSIS · 2022-04-29
- ModerateMasterPharm Recalls Sildenafil Troches Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Tadalafil 18 mg Capsules Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
Similar recalls
- ModerateProgesterone 200 mg Capsules Recalled for Lack of Processing Control
FDA (Drugs) · 2020-04-22
- ModerateProgesterone 100 mg SR Capsules Recalled for Lack of Processing Controls
FDA (Drugs) · 2019-02-06
- ModerateThe Medicine Shoppe Recalls Bi-Est Progesterone Capsules Due to Processing Control
FDA (Drugs) · 2020-04-22
- ModerateDr. Reddy's Recalls Progesterone Capsules Due to Dissolution Failures
FDA (Drugs) · 2021-03-10
- ModerateProgesterone Cream Recalled for Lack of Processing Control
FDA (Drugs) · 2020-04-22
- SevereProgesterone Injection Recalled Due to Sterility Concerns
FDA (Drugs) · 2013-07-10